Statistically tabulated results at the end of 12 weeks of therapy showed that patients suffering from Bronchial Asthma improved considerably in the vital Pulmonary Function Tests (PFT) with ASTHA-15 and also showed significant reduction in key asthmatic parameters like dyspnoea, wheezing, cough and rhonchi in comparison to the modern allopathic drugs. In addition, ASTHA-15 did not exhibit any of the side-effects normally observed with allopathic drugs. The results of the study have been published and a patent filed internationally for the formulation.

After conducting two such trials for over tow years, Herbal Specialties Limited (an enterprise of the Dalmia Group) have launched ASTHA-15 in select cities like Delhi, Bangalore, Ahmedabad, Mumbai and Patna in its first phase. Gradually the drug will be available all over the country.

DOSAGE
The recommended dosage for ASTHA-15 is 4 capsules per day for 13 weeks and is to be taken again only when there is a need. The company has priced the product in such a way that it is affordable to the common man.